ADAL anticorps (AA 1-267) (HRP)

N° du produit ABIN7143290

Détail du produit anti-ADAL anticorps (HRP)

Antigène: ADAL (Adenosine Deaminase-Like Protein (ADAL))

Épitope: AA 1-267

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp ADAL est conjugé à/à la HRP

Application: ELISA

Réactivité croisée: Humain

Purification: >95%, Protein G purified

Immunogène: Recombinant Human Adenosine deaminase-like protein (1-267AA)

Isotype: IgG

Information d'application

Indications d'application: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4

Agent conservateur: ProClin

Précaution d'utilisation: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C,-80 °C

Stockage commentaire: Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Détails sur ADAL

Antigène: ADAL (Adenosine Deaminase-Like Protein (ADAL))

Autre désignation: ADAL (ADAL Produits)

Synonymes: anticorps 4930578F03Rik, anticorps adal-a, anticorps zgc:109912, anticorps adenosine deaminase like, anticorps adenosine deaminase-like, anticorps adenosine deaminase-like protein, anticorps adenosine deaminase-like L homeolog, anticorps ADAL, anticorps Tc00.1047053503419.20, anticorps Tc00.1047053509105.60, anticorps Tb10.406.0070, anticorps LINJ_33_0250, anticorps LBRM_31_0560, anticorps LBRM_33_0250, anticorps LMJF_33_0235, anticorps Adal, anticorps adal.L, anticorps adal

Sujet:

Background: Putative nucleoside deaminase. May catalyze the hydrolytic deamination of adenosine or some similar substrate and play a role in purine metabolism.

Aliases: ADAL antibody, ADAL1 antibody, Adenosine deaminase-like protein antibody, EC 3.5.4.- antibody, Adenosine deaminase-like protein isoform 1 antibody, N6-mAMP deaminase antibody, HsMAPDA antibody, N6-methyl-AMP aminohydrolase antibody

UniProt: Q6DHV7

Pathways: Ribonucleoside Biosynthetic Process